Solid Biosciences Inc. Common Stock earnings per share and revenue
On 03 de nov. de 2025, SLDB reported earnings of -0.48 USD per share (EPS) for Q3 25, missing the estimate of -0.44 USD, resulting in a -7.26% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -15.29% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 16 analistas forecast an EPS of -0.51 USD, with revenue projected to reach -- USD, implying an aumentar of 6.25% EPS, and aumentar of 0.00% in Revenue from the last quarter.
FAQ
What were Solid Biosciences Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Solid Biosciences Inc. Common Stock reported EPS of -$0.48, missing estimates by -7.26%, and revenue of $0.00, 0% as expectations.
How did the market react to Solid Biosciences Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -15.29%, changed from $5.20 before the earnings release to $4.41 the day after.
When is Solid Biosciences Inc. Common Stock expected to report next?
The next earning report is scheduled for 04 de mar. de 2026.
What are the forecasts for Solid Biosciences Inc. Common Stock's next earnings report?
Based on 16
analistas, Solid Biosciences Inc. Common Stock is expected to report EPS of -$0.51 and revenue of -- for Q4 2025.